Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 09-2025 | 06-2025 | 03-2025 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,675,098 | 3,103,738 | 3,429,907 | 2,794,565 | 2,706,519 |
| Marketable Securities | 2,765,510 | 2,896,902 | 3,660,595 | 3,439,465 | 2,957,112 |
| Receivables | 2,258,823 | 2,406,207 | 2,187,003 | 1,946,888 | 2,196,622 |
| Inventories | 1,845,050 | 1,675,017 | 1,625,129 | 1,538,394 | 1,830,420 |
| Other current assets | 307,942 | 238,696 | 272,136 | 288,938 | 232,429 |
| TOTAL | $9,852,423 | $10,320,560 | $11,174,770 | $10,008,250 | $9,923,102 |
| Non-Current Assets | |||||
| PPE Net | 2,940,902 | 3,057,348 | 3,151,610 | 2,960,087 | 2,855,996 |
| Intangibles | 374,368 | 232,315 | 229,715 | 114,312 | 139,521 |
| Other Non-Current Assets | 1,328,954 | 1,238,171 | 1,164,499 | 1,037,936 | 948,619 |
| TOTAL | $4,644,224 | $4,527,834 | $4,545,824 | $4,112,335 | $3,944,136 |
| Total Assets | $14,496,650 | $14,848,400 | $15,720,590 | $14,120,580 | $13,867,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 688,154 | 536,500 | 541,077 | 465,868 | 511,170 |
| Other current liabilities | 1,078,419 | 987,095 | 814,628 | 645,460 | 720,230 |
| TOTAL | $2,097,293 | $1,818,476 | $1,851,104 | $1,375,631 | $1,684,688 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 137,766 | 116,477 | 106,991 | 101,026 | 55,047 |
| TOTAL | $189,978 | $177,194 | $172,107 | $157,291 | $113,377 |
| Total Liabilities | $2,287,271 | $1,995,671 | $2,023,211 | $1,532,923 | $1,798,066 |
| Shareholders' Equity | |||||
| Common Shares | 468,493 | 497,774 | 505,094 | 483,133 | 490,453 |
| Retained earnings | 11,286,750 | 11,920,520 | 12,747,870 | 11,552,390 | 11,063,420 |
| Other shareholders' equity | 1,696 | -44,209 | -40,454 | 89,210 | 47,741 |
| TOTAL | $12,209,380 | $12,852,730 | $13,697,380 | $12,587,670 | $12,069,160 |
| Total Liabilities And Equity | $14,496,651 | $14,848,401 | $15,720,591 | $14,120,593 | $13,867,226 |